Lumos Diagnostics Bolsters its POC Testing Platform

Lumos Diagnostics Bolsters its POC Testing Platform

Lumos Diagnostics, a subsidiary of Planet Innovation, announced this week it acquired RPS Diagnostics for an undisclosed price. RPS develops, manufactures and markets rapid, point-of-care diagnostic tests for a variety of infectious diseases and inflammatory conditions. The merged company will be called Lumos Diagnostics. This deal adds RPS’s FebriDx test, a rapid, in-office test that provides clinicians with a rapid assessment of the body’s immune response to an acute respiratory infection. Combining RPS’ biomarker technology and Lumos’ reader-based platform will create a strong pipeline of products. This deal caps off a relatively busy month for the laboratories, MRI... Read More »